Do you want to read an article? Please log in or register.
Relative Prognostic Importance and Optimal Levels of Risk Factors for Mortality and Cardiovascular Outcomes in Type 1 Diabetes
Type 1 Diabetes
RECOMMENDED
Related content
COMMENTED
Diabetes - GeneralType 2 Diabetes
Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes
N Engl J Med.
Rawshani A, Rawshani A, Franzén S, Sattar N, Eliasson B, Svensson AM, Zethelius B, Miftaraj M, McGuire DK, Rosengren A, Gudbjörnsdottir S
doi: 10.1056/NEJMoa1800256.
COMMENTED
Type 1 DiabetesType 2 Diabetes
Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study
★ 2
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Lancet Diabetes Endocrinol.
Holman N, Knighton P, Kar P, O'Keefe J, Curley M, Weaver A, Barron E, Bakhai C, Khunti K, Wareham NJ, Sattar N, Young B, Valabhji J
doi: 10.1016/S2213-8587(20)30271-0.
COMMENTED
Type 1 Diabetes
Association of Insulin Dose, Cardiometabolic Risk Factors, and Cardiovascular Disease in Type 1 Diabetes During 30 Years of Follow-up in the DCCT/EDIC Study
Diabetes Care.
Braffett BH, Dagogo-Jack S, Bebu I, Sivitz WI, Larkin M, Kolterman O, Lachin JM, DCCT/EDIC Research Group
doi: 10.2337/dc18-1574.
COMMENTED
Diabetes - GeneralType 2 Diabetes
Effect of population screening for type 2 diabetes and cardiovascular risk factors on mortality rate and cardiovascular events: a controlled trial among 1,912,392 Danish adults
Diabetologia.
Simmons RK, Griffin SJ, Witte DR, Borch-Johnsen K, Lauritzen T, Sandbæk A
doi: 10.1007/s00125-017-4323-2.
Type 1 Diabetes
Cardiovascular prognostic value of echocardiography and N terminal pro B-type natriuretic peptide in type 1 diabetes: The Thousand and 1 Study
Eur J Endocrinol.
Rørth R, Jørgensen PG, Andersen HU, Christoffersen C, Gøtze JP, Køber L, Rossing P, Jensen MT
doi: 10.1530/EJE-19-1015.
Diabetes - GeneralType 2 DiabetesGlycemic Control
Mitigating Cardiovascular Risk in Type 2 Diabetes With Antidiabetes Drugs: A Review of Principal Cardiovascular Outcome Results of EMPA-REG OUTCOME, LEADER, and SUSTAIN-6 Trials
Diabetes Care.
Kaul S
doi: 10.2337/
Type 1 DiabetesType 2 Diabetes
Prevalence of and Risk Factors for Diabetic Peripheral Neuropathy in Youth With Type 1 and Type 2 Diabetes: SEARCH for Diabetes in Youth Study
Diabetes Care.
Jaiswal M, Divers J, Dabelea D, Isom S, Bell RA, Martin CL, Pettitt DJ, Saydah S, Pihoker C, Standiford DA, Dolan LM, Marcovina S, Linder B, Liese AD, Pop-Busui R, Feldman EL
doi: 10.2337/dc17-0179.
Type 2 Diabetes
Arterial stiffness as a risk factor for cardiovascular events and all-cause mortality in people with Type 2 diabetes
Diabet Med.
Sharif S, Visseren FLJ, Spiering W, de Jong PA, Bots ML, Westerink J; SMART study group
doi: 10.1111/dme.13954.
Diabetes - GeneralType 2 Diabetes
Cardiovascular Outcomes According to Urinary Albumin and Kidney Disease in Patients With Type 2 Diabetes at High Cardiovascular Risk: Observations From the SAVOR-TIMI 53 Trial
JAMA Cardiol.
Scirica BM, Mosenzon O, Bhatt DL, Udell JA, Steg PG, McGuire DK, Im K, Kanevsky E, Stahre C, Sjöstrand M, Raz I, Braunwald E
doi: 10.1001/